Article
Genome-Wide Association Study of NAFLD Using Electronic Health Records.
Hepatology communications - 1 Feb 2022
Fairfield Cameron J, Drake Thomas M, Pius Riinu, Bretherick Andrew D, Campbell Archie, Clark David W, Fallowfield Jonathan A, Hayward Caroline, Henderson Neil C, Joshi Peter K, Mills Nicholas L, Porteous David J, Ramachandran Prakash, Semple Robert K, Shaw Catherine A, Sudlow Cathie L M, Timmers Paul R H J, Wilson James F, Wigmore Stephen J, Harrison Ewen M, Spiliopoulou Athina
Abstract excerpt
Genome-wide association studies (GWAS) have identified several risk loci for nonalcoholic fatty liver disease (NAFLD). Previous studies have largely relied on small sample sizes and have assessed quantitative traits. We performed a case-control GWAS in the UK Biobank using recorded diagnosis of NAFLD based on diagnostic codes recommended in recent consensus guidelines. We performed a GWAS of 4,761 cases of NAFLD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
